Official FDA minutes confirm the previously announced End-of-Phase 2 meeting outcomes and provide additional detail on the planned Phase 3 ...

For decades, the commercial distribution of protein powders and creatine monohydrate targeted a narrow demographic: strength athletes and bodybuilders. The broader consumer market frequently viewed ...

Abstract: A variable latency adder (VLA) reduces average addition time by using speculation: the exact arithmetic function is replaced by an approximated one, that is ...

University Institute of Technology of Wood, University of Yaoundé I, Mbalmayo, Cameroon. 2 ISABEE of University of Ebolowa, ...

Abstract: This article is concerned with the improvement of robust control methodology and its application in stabilizing a class of high-order nonlinear systems with multiple unknown time-varying ...

Exploring the engineering behind advanced printheads, durable ink systems, and efficient roll-to-roll production.

LLVM powers the core development tools, operating systems, and most applications at Apple Computer, where it long ago ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been ...

Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...

Radiation therapy remains a central modality in cancer treatment, but normal-tissue toxicity and long-term stochastic effects ...